Fritextsökning
Artiklar per år
Innehållstyper
-
Nya blodtrycksgener identifierade
Åtta hittills okända gener som påverkar blodtrycket har kartlagts i en stor internationell studie.
-
Biotage i patenttvist om labbutrustning
Det svenska bolaget Biotage har fått en stämningsansökan emot sig i USA. -Motparten saknar fog för påståendet, säger Biotages vd Torben Jørgensen.
-
Tigran får fransk order
Genom partnerbolaget Advanced Medical Products har Tigran tagit i sin hittills största order sedan försäljningsstarten ifjol.
-
50 får gå från Pfizer - vd slutar
Pfizers vd Niklas Prager lämnar bolaget i samband med en omorganisation som träder i kraft i april.
-
Svenska läkare får immunologpris
De får dela på 400 000 kronor i jakten på bättre behandlingar mot psoriasis och Crohns sjukdom.
-
Bra immunförsvar minskar risk för cancer
Genetiska variationer i immunförsvaret påverkar risken att drabbas av livmoderhalscancer. Det visar en ny avhandling som läggs fram nästa vecka.
-
Ny kombinationsläsare för mikrotiterplattor
Synergy Mx är en ny multitalang från BioTek som mäter fluorescens, absorbans och luminiscens.
-
Orexo mot nya marknader
Smärtbehandlingen Abstral har godkänts för försäljning i Frankrike och Spanien. Det ger Orexo rätt till en milstolpeutbetalning.
-
Instrument för skräddarsydd behandling snart här
En apparat stor som en mobiltelefon kan komma att revolutionera förskrivningen av läkemedel.
-
EU vill upphäva GMO-förbud
Österrike kan tvingas tillåta odling av genmodifierad majs. Detta trots att landet införde förbud mot grödan för tio år sedan.
-
Major changes to the Q-Med board
The nomination committee wants to replace half of the existing board, including the current Chairman. An Extraordinary General Meeting will take place on February 4.
-
Faster sales but less profits for Probi
The probiotic company increases its turnover, and the net results are twice as large as last year.
-
Swedish top scientists to EMBO
Two Swedish top scientists will have a really good chance to influence European life science research from now on. One is from the Karolinska Institutet, and one is from the University of Uppsala.
-
Symphogen buys tumor blocking technology
The seller is a pioneer in developing ligand traps to treat cancer and other diseases. "An excellent fit with our scientific and strategic focus," said Kirsten Drejer, CEO of Symphogen. Ph.D.
-
Re-painting the big pig-ture
Why do tame pigs show such variety in colouring, when their wild relatives are so plain? Swedish researchers know who is to blame. But the big question is why.
-
Athera signs production partnership
The companys novel cardiovascular product will be manufactured in Germany.
-
Teams up with leading dermatologist
Tripep has signed a letter of intent with a major Japanese specialty pharma company to bring their wound healing treatment to a big market.
-
Test if you carry the fat virus
In a soon future there may be a quick and simple test that could show if you are infected with Ad-36, a human adenovirus that can make you over-weight.
-
Go ahead for leg wound study
Tripep starts a phase II-study of their wound healing joint venture project.
-
Pfizer lays a chunky bid on Wyeth
The merger of two pharma giants is the largest industry deal so far this year. Pfizer will acquire Wyeth in a cash-and-stock transaction currently valued at approximately $68 billion. The Boards of Directors of both companies have said yes to the deal that may lead to lay-offs of some 8,000 persons.
-
Orexo opens doors eastwards
The drug delivery company has signed a deal for selling a cancer pain treatment in China. "An ideal partner for us" says Torbjörn Bjerke, CEO of Orexo.
-
Lundbeck divests companies
The company sells all shares in one listed company plus divests four small private equity funds, for a three-figured million sum.
-
New CEO to Promedvi
Sigrun Axelsson has taken on the leadership of the Lund-based medtech company.
-
New member to Active board
The Election Committee of Active Biotech proposes a very experienced financial sector executive to join the company board. Five existing members are also to be re-elected at the AGM in May.
BREAKING